These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 8102130)
1. c-erbB-2 oncoprotein in screen-detected breast carcinoma: an immunohistological study. Soomro S; Taylor P; Shepard HM; Feldmann M; Sinnett HD; Shousha S Int J Cancer; 1993 Aug; 55(1):63-5. PubMed ID: 8102130 [TBL] [Abstract][Full Text] [Related]
2. C-erbB-2 oncogene protein in in situ and invasive lobular breast neoplasia. Porter PL; Garcia R; Moe R; Corwin DJ; Gown AM Cancer; 1991 Jul; 68(2):331-4. PubMed ID: 1676930 [TBL] [Abstract][Full Text] [Related]
3. c-erbB-2 expression in different histological types of invasive breast carcinoma. Soomro S; Shousha S; Taylor P; Shepard HM; Feldmann M J Clin Pathol; 1991 Mar; 44(3):211-4. PubMed ID: 1672872 [TBL] [Abstract][Full Text] [Related]
4. Overexpression of the c-erbB-2 oncoprotein: why does this occur more frequently in ductal carcinoma in situ than in invasive mammary carcinoma and is this of prognostic significance? Barnes DM; Bartkova J; Camplejohn RS; Gullick WJ; Smith PJ; Millis RR Eur J Cancer; 1992; 28(2-3):644-8. PubMed ID: 1350456 [TBL] [Abstract][Full Text] [Related]
5. Nuclear and flow cytometric characteristics associated with overexpression of the c-erbB-2 oncoprotein in breast carcinoma. Poller DN; Galea M; Pearson D; Bell J; Gullick WJ; Elston CW; Blamey RW; Ellis IO Breast Cancer Res Treat; 1991 Dec; 20(1):3-10. PubMed ID: 1687505 [TBL] [Abstract][Full Text] [Related]
6. C-erbB-2 protein and neuroendocrine expression in intraductal carcinomas of the breast. Lilleng R; Hagmar BM; Nesland JM Mod Pathol; 1992 Jan; 5(1):41-7. PubMed ID: 1347423 [TBL] [Abstract][Full Text] [Related]
7. Expression of p53 protein in infiltrating and in-situ breast carcinomas. Walker RA; Dearing SJ; Lane DP; Varley JM J Pathol; 1991 Nov; 165(3):203-11. PubMed ID: 1684809 [TBL] [Abstract][Full Text] [Related]
8. In situ distribution of oncogene products and growth factor receptors in breast carcinoma: c-erbB-2 oncoprotein, EGFr, and PDGFr-beta-subunit. Kommoss F; Colley M; Hart CE; Franklin WA Mol Cell Probes; 1990 Feb; 4(1):11-23. PubMed ID: 1969111 [TBL] [Abstract][Full Text] [Related]
9. p53 protein expression in human breast carcinoma: relationship to expression of epidermal growth factor receptor, c-erbB-2 protein overexpression, and oestrogen receptor. Poller DN; Hutchings CE; Galea M; Bell JA; Nicholson RA; Elston CW; Blamey RW; Ellis IO Br J Cancer; 1992 Sep; 66(3):583-8. PubMed ID: 1355662 [TBL] [Abstract][Full Text] [Related]
10. c-erbB-2 overexpression and histological type of in situ and invasive breast carcinoma. Somerville JE; Clarke LA; Biggart JD J Clin Pathol; 1992 Jan; 45(1):16-20. PubMed ID: 1346789 [TBL] [Abstract][Full Text] [Related]
11. p53 and c-erbB-2 protein expression in breast carcinomas. An immunohistochemical study including correlations with receptor status, proliferation markers, and clinical stage in human breast cancer. Barbareschi M; Leonardi E; Mauri FA; Serio G; Dalla Palma P Am J Clin Pathol; 1992 Oct; 98(4):408-18. PubMed ID: 1357956 [TBL] [Abstract][Full Text] [Related]
12. Estrogen and progesterone receptor and c-erbB-2 oncoprotein analysis in pure in situ breast carcinoma: an immunohistochemical study. Wilbur DC; Barrows GH Mod Pathol; 1993 Mar; 6(2):114-20. PubMed ID: 8097877 [TBL] [Abstract][Full Text] [Related]
13. Biologic characteristics of breast cancer detected by mammography and by palpation in a screening program: a pilot study. Tweedie E; Tonkin K; Kerkvliet N; Doig GS; Sparrow RK; O'Malley FP Clin Invest Med; 1997 Oct; 20(5):300-7. PubMed ID: 9336655 [TBL] [Abstract][Full Text] [Related]
14. [Expression of the c-erbB-2 oncoprotein in mammary Paget's disease. Immunohistochemical study by using 3 antibodies]. Edorh A; Parache RM; Migeon C; N'Sossani B; Rihn B Pathol Biol (Paris); 1995 Sep; 43(7):584-9. PubMed ID: 8570262 [TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical demonstration of c-erbB-2 protein in mammary ductal carcinoma in situ. Bartkova J; Barnes DM; Millis RR; Gullick WJ Hum Pathol; 1990 Nov; 21(11):1164-7. PubMed ID: 1977679 [TBL] [Abstract][Full Text] [Related]
16. c-erB-2 oncoprotein expression in malignant and nonmalignant breast tissue. McCann A; Johnston PA; Dervan PA; Gullick WJ; Carney DN Ir J Med Sci; 1989 Jun; 158(6):137-40. PubMed ID: 2570047 [TBL] [Abstract][Full Text] [Related]
17. A comparison of clinical-pathological characteristics between symptomatic and interval breast cancer. Meshkat B; Prichard RS; Al-Hilli Z; Bass GA; Quinn C; O'Doherty A; Rothwell J; Geraghty J; Evoy D; McDermott EW Breast; 2015 Jun; 24(3):278-82. PubMed ID: 25771080 [TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical distribution of c-erbB-2 in infiltrating and in situ breast cancer. Gusterson BA; Machin LG; Gullick WJ; Gibbs NM; Powles TJ; Price P; McKinna A; Harrison S Int J Cancer; 1988 Dec; 42(6):842-5. PubMed ID: 2903851 [TBL] [Abstract][Full Text] [Related]
19. Clinical and prognostic significance of the expression of the c-erbB-2 and c-erbB-3 oncoproteins in primary and metastatic malignant melanomas and breast carcinomas. Bodey B; Bodey B; Gröger AM; Luck JV; Siegel SE; Taylor CR; Kaiser HE Anticancer Res; 1997; 17(2B):1319-30. PubMed ID: 9137492 [TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical evaluation of c-erbB-2 oncogene expression in ductal carcinoma in situ and atypical ductal hyperplasia of the breast. Lodato RF; Maguire HC; Greene MI; Weiner DB; LiVolsi VA Mod Pathol; 1990 Jul; 3(4):449-54. PubMed ID: 2170971 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]